Razvodovskii et al., 2007 - Google Patents
Effect of tavamin on the content of free amino acids in rat heart under alcohol withdrawal syndrome conditionsRazvodovskii et al., 2007
- Document ID
- 5098483823122177027
- Author
- Razvodovskii Y
- Smirnov V
- Publication year
- Publication venue
- Pharmaceutical Chemistry Journal
External Links
Snippet
The effect of the new amino acid preparation tavamin on the free amino acid pool in heart has been studied under alcohol withdrawal syndrome (AWS) conditions in rats. The AWS in rats alcoholized according to Majchrowicz and Hunt leads to a pronounced dysbalance in …
- 150000001413 amino acids 0 title abstract description 20
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lubec et al. | Amino acids: chemistry, biology and medicine | |
| Morin et al. | MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates | |
| Derave et al. | Muscle carnosine metabolism and β-alanine supplementation in relation to exercise and training | |
| Svalbe et al. | Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats | |
| Kim et al. | Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice | |
| Eisinger et al. | Reactive oxygen species, antioxidant status and fibromyalgia | |
| EP1536781A1 (en) | Nutritional or pharmaceutical compositions for increasing the creatine response of organisms | |
| TW201417807A (en) | Methods for improving thyroid function in a subject | |
| Aricioglu-Kartal et al. | Effect of chronic morphine treatment on the biosynthesis of agmatine in rat brain and other tissues | |
| JPS61247354A (en) | Nutrinet composition | |
| Knol et al. | Amino acid metabolism in kidney health and disease | |
| OKUMURA et al. | Effect of excess of individual essential amino acids in diets on chicks | |
| BRPI1011103B1 (en) | COMPOSITION TO TREAT MALE INFERTILITY AND USES OF D-ASPARTIC ACID AND L-ASPARTIC ACID | |
| Scaglia | New insights in nutritional management and amino acid supplementation in urea cycle disorders | |
| Razvodovskii et al. | Effect of tavamin on the content of free amino acids in rat heart under alcohol withdrawal syndrome conditions | |
| US20080076721A1 (en) | Use of branched chain fatty acid amino acid salts and compositions thereof | |
| El Hage et al. | Metabolic fate of a high concentration of glutamine and glutamate in rat brain slices: a 13C NMR study | |
| Hwang et al. | Changes in the levels of low molecular weight metabolites in the mouse cerebellum following treatment with methylmercury | |
| Darmaun et al. | Use of isotope dilution methods to investigate glutamine metabolism in vivo in humans | |
| Watford et al. | Dietary glutamine suppresses endogenous glutamine turnover in the rat | |
| Maksimovich et al. | Characterization of the Pool of Amino Acids and Their Functional Significance in The Rat Brain | |
| Darmaun et al. | 8 Use of Isotope Dilution | |
| CN101120918A (en) | Compound amino acid injection composition suitable for liver disease patient | |
| Manner et al. | The antinociceptive effects of branched-chain amino acids: evidence for their ability to potentiate morphine analgesia | |
| Jarowski et al. | Effect of tryptophan on toxicity and depressant effects of barbiturates and ethanol in rats |